NutriBand (NTRB) Operating Expenses (2016 - 2026)
NutriBand (NTRB) posted Operating Expenses of $1.7 million for Q2 2026, up 18.72% sequentially from $1.4 million in Q1 2026, and down 18.89% YoY from $2.1 million in Q2 2025.
NutriBand (NTRB) Operating Expenses (2016 - 2026) Analysis & Trends
NutriBand has reported Operating Expenses for 11 years, with the latest figure at $1.7 million in Q2 2026.
- Quarterly Operating Expenses fell 18.89% year-over-year to $1.7 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $10.0 million (down 18.4% YoY) and the FY2026 annual result came in at $10.4 million, down 16.66% from the prior year.
- Operating Expenses climbed to $1.7 million in Q2 2026 per NTRB's latest filing, from $1.4 million in the prior quarter.
- Over five years, Operating Expenses peaked at $6.2 million in Q1 2025 and troughed at $1.2 million in Q2 2022.
- A 5-year average of $2.3 million and a median of $2.0 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2025 and 2026: Operating Expenses jumped 238.68% in 2025, then sank 77.07% in 2026.
- Over 5 years, Operating Expenses stood at $1.7 million in 2022, then rose by 27.33% to $2.2 million in 2023, then slipped by 3.66% to $2.1 million in 2024, then soared by 103.91% to $4.2 million in 2025, then tumbled by 60.07% to $1.7 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $1.7 million, $1.4 million, and $4.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 541.02 Mn |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | 1.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 1.69 Mn |
| Jan 31, 2026 | 1.42 Mn |
| Oct 31, 2025 | 4.23 Mn |
| Jul 31, 2025 | 2.63 Mn |
| Apr 30, 2025 | 2.08 Mn |
| Jan 31, 2025 | 6.20 Mn |
| Oct 31, 2024 | 2.07 Mn |
| Jul 31, 2024 | 1.85 Mn |
| Apr 30, 2024 | 2.30 Mn |
| Jan 31, 2024 | 1.83 Mn |
| Oct 31, 2023 | 2.15 Mn |
| Jul 31, 2023 | 1.48 Mn |
| Apr 30, 2023 | 1.49 Mn |
| Jan 31, 2023 | 2.21 Mn |
| Oct 31, 2022 | 1.69 Mn |
| Jul 31, 2022 | 1.49 Mn |
| Apr 30, 2022 | 1.16 Mn |
| Jan 31, 2022 | 4.27 Mn |
| Oct 31, 2021 | 1.82 Mn |
| Jul 31, 2021 | 695,981.00 |